The research focus of Banerjee-Chow-Broker lab is the pathobiology of the Human Papillomaviruses (HPV), ranging from productive infection, dysplasias, to malignancies. The lab uses 2D cell culture, 3D ...

Aug. 14, 2024 — A vaccine against cancer-causing human papillomaviruses (HPV) is intended to help increase the rate of HPV vaccinations, particularly in developing ... New Study Finds 40-Percent ...

Most recently, Dr. Tumban’s research has been focused on the development of next-generation vaccines against human papillomaviruses (HPVs)—the ... strategies to increase immune responses against HPV ...

In this study, we found that human papillomaviruses (HPV) residing in the skin help virus-specific immune cells detect and suppress the expansion of mutant skin cells, thereby promoting the normal ...

Non-persistent human papillomavirus (HPV) infections are characterized by a sharp increase in viral load followed by a long plateau, according to a study published January 21st in the open-access ...

It is estimated that 99 percent of cases of cervical cancer are caused by human papillomaviruses (HPV), frequently acquired through sexual contact, although only specific types of HPV are a risk ...

Most recently, Dr. Tumban’s research has been focused on the development of next-generation vaccines against human papillomaviruses (HPVs)—the ... strategies to increase immune responses against HPV ...